The optimization of helper T lymphocyte (HTL) function in vaccine development
- 1 October 1998
- journal article
- review article
- Published by Springer Science and Business Media LLC in Immunologic Research
- Vol. 18 (2), 79-92
- https://doi.org/10.1007/bf02788751
Abstract
Helper T lymphocyte (HTL) responses play an important role in the induction of both humoral and cellular immune responses. Therefore, HTL epitopes are likely to be a crucial component of prophylactic and immunotherapeutic vaccines. For this reason, Pan DR helper T cell epitopes (PADRE), engineered to bind most common HLA-DR molecules with high affinity and act as powerful immunogens, were developed. Short linear peptide constructs comprising PADRE andPlasmodium-derived B cell epitopes induced antibody responses comparable to more complex multiple antigen peptides (MAP) constructs in mice. These antibody responses were composed mostly of the IgG subclass, reactive against intact sporozoites, inhibitory of schizont formation in liver invasion assays, and protective against sporozoite challenge in vivo. The PADRE HTL epitope has also been shown to augment the potency of vaccines designed to stimulate a cellular immune response. Using a HBV transgenic murine model, it was found that CTL tolerance was broken by PADRE-CTL epitope lipopeptide, but not by a similar construct containing a conventional HTL epitope. There are a number of prophylactic vaccines that are of limited efficacy, require multiple boosts, and/or confer protection to only a fraction of the immunized population. Also, in the case of virally infected or cancerous cells, new immunotherapeutic vaccines that induce strong cellular immune responses are desirable. Therefore, optimization of HTL function by use of synthetic epitopes such as PADRE or pathogen-derived, broadly crossreactive epitopes holds promise for a new generation of highly efficacious vaccines.Keywords
This publication has 142 references indexed in Scilit:
- Peptide-based cancer vaccinesCurrent Opinion in Immunology, 1996
- Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA moleculesHuman Immunology, 1996
- Nomenclature for factors of the HLA system, 1995Human Immunology, 1995
- Sequence variability of hepatitis C virus and its clinical relevanceJournal of Viral Hepatitis, 1994
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- Cell-Mediated Immune Response to Human Immunodeficiency Virus (HIV) Type 1 in Seronegative Homosexual Men with Recent Sexual Exposure to HIV-1The Journal of Infectious Diseases, 1992
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989